MARKET

BRTX

BRTX

Biorestorative Therapies Inc
NASDAQ
1.580
-0.040
-2.47%
After Hours: 1.520 -0.06 -3.80% 19:50 10/26 EDT
OPEN
1.580
PREV CLOSE
1.620
HIGH
1.580
LOW
1.450
VOLUME
35.01K
TURNOVER
--
52 WEEK HIGH
34.00
52 WEEK LOW
1.280
MARKET CAP
2.18M
P/E (TTM)
-0.0726
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at BRTX last week (1012-1016)?
Weekly Report · 10/19 09:16
Weekly Report: what happened at BRTX last week (1005-1009)?
Weekly Report · 10/12 09:17
BioRestorative Therapies Strengthens Board With New Director
TipRanks · 10/09 20:31
BioRestorative Therapies Cut to Hold From Buy by Maxim Group
Dow Jones · 10/06 20:13
Maxim Group Downgrades BioRestorative Therapies to Hold
Benzinga · 10/06 20:03
BioRestorative Therapies downgraded to Hold from Buy at Maxim
TipRanks · 10/06 12:00
Weekly Report: what happened at BRTX last week (0928-1002)?
Weekly Report · 10/05 09:17
Weekly Report: what happened at BRTX last week (0921-0925)?
Weekly Report · 09/28 09:16
More
About BRTX
BioRestorative Therapies, Inc. is engaged in developing therapeutic products using cell and tissue protocols, primarily involving adult stem cells. The Company has two core programs that relate to the treatment of disc/spine disease and metabolic disorders. Its lead cell therapy candidate, BRTX-100, is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow. It has commenced a Phase II clinical trial using BRTX-100 to treat chronic lower back pain arising from degenerative disc disease. The Company is engaged in developing a cell-based therapy candidate, ThermoStem Program, which targets obesity and metabolic disorders using brown adipose (fat) derived stem cells to generate brown adipose tissue (BAT). It has also licensed an investigational curved needle device designed to deliver cells and/or other therapeutic products or material to the spine and discs. It also operates a commercial biocosmeceutical platform.

Webull offers BioRestorative Therapies Inc stock information, including NASDAQ: BRTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BRTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BRTX stock methods without spending real money on the virtual paper trading platform.